Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Wei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6848-1432; OpenAlex author ID A5100751020. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers

Papers 3

  1. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Last author DOI 10.1038/srep11836↗
  2. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine an… Last author DOI 10.3892/ijo.2015.3156↗
  3. PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradat… Co-author DOI 10.3892/or.2014.3266↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Tao · 3 shared papers, 2014–2015 · strength 0.14
  2. Qiaoming Zhi · 2 shared papers, 2015 · strength 0.10
  3. Meng Shen · 2 shared papers, 2015 · strength 0.10
  4. Mengyao Wu · 2 shared papers, 2014–2015 · strength 0.09
  5. Wenjie Wang · 1 shared paper, 2015 · strength 0.05
  6. Mengyao Wu · 1 shared paper, 2015 · strength 0.05
  7. Daoming Li · 1 shared paper, 2015 · strength 0.05
  8. Zekuan Xu · 1 shared paper, 2014 · strength 0.04
  9. Zheng Chen · 1 shared paper, 2014 · strength 0.04
  10. Xin Xie · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.